Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
AbViro
Welcome,
Profile
Billing
Logout
Products
Diseases
Products
Trials
News
||
||||||||
AV-1
/
AbViro
Trial completion, Trial completion date, Trial primary completion date:
A Study to Determine the Safety of AV-1, an Antibody Being Developed for Treatment of Dengue, in Healthy Volunteers
(clinicaltrials.gov) - Jun 3, 2022
P1a
, N=42, Completed,
Sponsor: AbViro LLC
Recruiting --> Completed | Trial completion date: Oct 2020 --> Jul 2021 | Trial primary completion date: Oct 2020 --> Jul 2021
|
|||||||||
AV-1
/
AbViro
New P1 trial:
A Study to Determine the Safety of AV-1, an Antibody Being Developed for Treatment of Dengue, in Healthy Volunteers
(clinicaltrials.gov) - Feb 17, 2020
P1a
, N=40, Recruiting,
Sponsor: AbViro LLC